SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026884
Filing Date
2018-11-05
Accepted
2018-11-05 16:44:36
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 2018 10-Q snss-10q_20180930.htm 10-Q 1034684
2 EX-31.1 snss-ex311_8.htm EX-31.1 16677
3 EX-31.2 snss-ex312_7.htm EX-31.2 16851
4 EX-32.1 snss-ex321_9.htm EX-32.1 9357
5 GRAPHIC ggpq15tpobzx000001.jpg GRAPHIC 3336
  Complete submission text file 0001564590-18-026884.txt   3397401

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20180930.xml EX-101.INS 582488
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20180930.xsd EX-101.SCH 36489
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20180930_cal.xml EX-101.CAL 34280
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20180930_def.xml EX-101.DEF 92406
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20180930_lab.xml EX-101.LAB 254210
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20180930_pre.xml EX-101.PRE 166713
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 181160435
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences